Microvascular Disease Exercise Trial (MOVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02045459
Recruitment Status : Active, not recruiting
First Posted : January 24, 2014
Last Update Posted : May 16, 2018
Astellas Pharma Global Development, Inc.
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Jamieson Bourque, MD, University of Virginia

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2020
  Estimated Study Completion Date : July 2021